BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Christodoulidis G, Koumarelas KE, Kouliou MN. Revolutionizing gastric cancer treatment: The potential of immunotherapy. World J Gastroenterol 2024; 30(4): 286-289 [PMID: 38313231 DOI: 10.3748/wjg.v30.i4.286]
URL: https://www.wjgnet.com/1007-9327/full/v30/i4/286.htm
Number Citing Articles
1
Gabriel Samasca, Claudia Burz, Irena Pintea, Adriana Muntean, Diana Deleanu, Iulia Lupan, Vasile Bintintan. A New Medical Evaluation for Gastric Cancer Patients to Increase the Success Rate of Immunotherapy: A 2024 UpdatePharmaceuticals 2024; 17(9): 1121 doi: 10.3390/ph17091121
2
Guodong Liang, Yuehan Ma, Ping Deng, Shufeng Li, Chunyan He, Haihang He, Hairui Liu, Yunda Fan, Ze Li. Role of cell-based therapies in digestive disorders: Obstacles and opportunitiesRegenerative Therapy 2025; 29: 1 doi: 10.1016/j.reth.2025.02.009
3
Zijie Wei, Ziqian Kou, Yun Luo, Yu Cheng. DNA methyltransferase 3A: A prognostic biomarker and potential target for immunotherapy in gastric cancerMedicine 2025; 104(7): e41578 doi: 10.1097/MD.0000000000041578
4
Yuxin Huang, Yi Hu. Impact of helicobacter pylori infection on the efficacy of ICIs in gastric cancerBMC Cancer 2025; 25(1) doi: 10.1186/s12885-025-14436-x
5
Yonggang Tian, Yunqian Xie, Guirong Yi, Fanqi Wu, Xiaoyu Dang, Feihu Bai, Jun Wang, Dekui Zhang. Prognostic Value and Therapeutic Significance of CCL Chemokines in Gastric CancerCurrent Medicinal Chemistry 2024; 31(42): 7043 doi: 10.2174/0109298673315146240731100101
6
Andrzej S Tarnawski. Editor-in-Chief articles of choice and comments from January to June 2024World Journal of Gastroenterology 2024; 30(34): 3875-3882 doi: 10.3748/wjg.v30.i34.3875
7
Bo-Ya Li, Hui-Ling Li, Fei-Er Zeng, Xuan-Yu Luan, Bi-Qing Liu, Zhi-Zhou Wang, Lan Zhang, Xian-Zhe Dong. Identification of PD-L1-related biomarkers for selecting gastric adenocarcinoma patients for PD-1/PD-L1 inhibitor therapyDiscover Oncology 2025; 16(1) doi: 10.1007/s12672-025-02515-1
8
Jane E. Rogers, Qiong Gan, Rebecca E. Waters, Ashley A. Horak, Jaffer A. Ajani. Targeted and combination immunotherapies using biologics for gastric cancer: the state-of-the-artExpert Opinion on Biological Therapy 2024; 24(10): 1005 doi: 10.1080/14712598.2024.2401622
9
Hui Yuan, Miao Bao, Minqiang Chen, Junhao Fu, Shian Yu. Advances in Immunotherapy and Targeted Therapy for Gastric Cancer: A Comprehensive ReviewBritish Journal of Hospital Medicine 2025; 86(3): 1 doi: 10.12968/hmed.2024.0759
10
Obed Boadi Amissah, Rajesh Basnet, Wenfang Chen, Jean de Dieu Habimana, Belinda Edwina Baiden, Osei Asibey Owusu, Babangida Jabir Saeed, Zhiyuan Li. Enhancing antitumor response by efficiently generating large-scale TCR-T cells targeting a single epitope across multiple cancer antigensCellular Immunology 2024; : 104827 doi: 10.1016/j.cellimm.2024.104827
11
Xiaodan Jiang, Xun Li, Yang Li, Yu Zhang, Xinliang Gu, Wei Zong, Xianjuan Shen, Shaoqing Ju. Systematic assessment of serum i-tRF-AsnGTT in gastric cancer: a potential clinical biomarkerCarcinogenesis 2025; 46(1) doi: 10.1093/carcin/bgae044
12
Yang-Kun Wang, Ping Li, Hai-Ying He, Fa-Shun Zhang, Xiao-Ling Jiang, Ren-Bing Zhang, Su-Nan Wang, Si-Liang Xu. Relationship between gastric mucosal atrophy, cystic dilatation, and histopathological characteristicsBMC Gastroenterology 2025; 25(1) doi: 10.1186/s12876-025-03662-z
13
Margherita Ratti, Elena Orlandi, Ilaria Toscani, Stefano Vecchia, Elisa Anselmi, Jens Claus Hahne, Michele Ghidini, Chiara Citterio. Emerging Therapeutic Targets and Future Directions in Advanced Gastric Cancer: A Comprehensive ReviewCancers 2024; 16(15): 2692 doi: 10.3390/cancers16152692
14
Ming Zhou, Xiaozhe Mao, Kanger Shen, Qin Zhan, Haoxiang Ni, Chun Liu, Ziyi Huang, Rui Li. FBLN2 inhibits gastric cancer proliferation and metastasis via the TGFβ/TGIF2 pathwayPathology - Research and Practice 2025; 269: 155899 doi: 10.1016/j.prp.2025.155899
15
Fares E.M. Ali, Islam M. Ibrahim, Hanan S. Althagafy, Emad H.M. Hassanein. Role of immunotherapies and stem cell therapy in the management of liver cancer: A comprehensive reviewInternational Immunopharmacology 2024; 132: 112011 doi: 10.1016/j.intimp.2024.112011